Induction of differentiation by pyruvate and DMEM in the human retinal pigment epithelium cell line ARPE-19

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 10, 2011, Pages 7148-7159

  Ahmado, Ahmad ^a,b   Carr, Amanda Jayne ^a   Vugler, Anthony A ^a   Semo, Ma'ayan ^a   Gias, Carlos ^a   Lawrence, Jean M ^a   Chen, Li Li ^a   Chen, Fred K ^a,b   Turowski, Patric ^c   da Cruz, Lyndon ^a,b   Coffey, Peter J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CYANO 4 HYDROXYCINNAMIC ACID; CELLULAR RETINOID BINDING PROTEIN; CYTOKERATIN 8; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MELANOCYTE PROTEIN PMEL 17; MERTK PROTEIN; MESSENGER RNA; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN TYROSINE KINASE; PYRUVIC ACID; RETINAL PIGMENT EPITHELIUM 65 PROTEIN; RETINOID BINDING PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VISUAL PIGMENT; 11 CIS RETINAL BINDING PROTEIN; 11-CIS-RETINAL-BINDING PROTEIN; BIOLOGICAL MARKER; CARRIER PROTEIN; EYE PROTEIN; MERTK PROTEIN, HUMAN; ONCOPROTEIN; RPE65 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE RESISTANCE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; DULBECCOS MODIFIED EAGLES MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN RETINAL PIGMENT EPITHELIUM CELL LINE ARPE 19; IMMUNOCYTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PHOTORECEPTOR OUTER SEGMENT; PIGMENT EPITHELIUM; PIGMENTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; CELL CULTURE; CYTOLOGY; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; PHAGOCYTOSIS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PYRUVIC ACID; RECEPTOR PROTEIN-TYROSINE KINASES; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80155192566     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6374     Document Type: Article

References (80)

1. Opas M. Expression of the differentiated phenotype by epithelial cells in vitro is regulated by both biochemistry and mechanics of the substratum. Dev Biol. 1989;131:281-293.
2. McKay BS, Burke JM. Separation of phenotypically distinct subpopulations of cultured human retinal pigment epithelial cells. Exp Cell Res. 1994;213:85-92.
3. Hu J, Bok D. A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol Vis. 2001;7:14-19.
4. Alge CS, Suppmann S, Priglinger SG, et al. Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells. Invest Ophthalmol Vis Sci. 2003;44:3629-3641.
5. Opas M, Dziak E. Effects of substrata and method of tissue dissociation on adhesion, cytoskeleton, and growth of chick retinal pigmented epithelium in vitro. In Vitro Cell Dev Biol. 1988;24: 885-892.
6. Opas M. Substratum mechanics and cell differentiation. Int Rev Cytol. 1994;150:119-137.
7. Luo Y, Zhuo Y, Fukuhara M, Rizzolo LJ. Effects of culture conditions on heterogeneity and the apical junctional complex of the ARPE-19 cell line. Invest Ophthalmol Vis Sci. 2006;47:3644-3655.
8. Krugluger W, Seidel S, Steindl K, Binder S. Epidermal growth factor inhibits glycogen synthase kinase-3 (GSK-3) and beta-catenin transcription in cultured ARPE-19 cells. Graefes Arch Clin Exp Ophthalmol. 2007;245:1543-1548.
9. Steindl-Kuscher K, Krugluger W, Boulton ME, et al. Activation of the beta-catenin signaling pathway and its impact on RPE cell cycle. Invest Ophthalmol Vis Sci. 2009;50:4471-4476.
10. Maminishkis A, Chen S, Jalickee S, et al. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci. 2006;47:3612-3624.
11. Dunn KC, Otaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62:155-169.
12. Carr AJ, Vugler A, Lawrence J, et al. Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol Vis. 2009;15:283-295.
13. Biesemeier A, Kreppel F, Kochanek S, Schraermeyer U. The classical pathway of melanogenesis is not essential for melanin synthesis in the adult retinal pigment epithelium. Cell Tissue Res. 2010;339:551-560.
14. Wang Z, Dillon J, Gaillard ER. Antioxidant properties of melanin in retinal pigment epithelial cells. Photochem Photobiol. 2006;82: 474-479.
15. Song Q, Risco R, Latina M, Berthiaume F, Nahmias Y, Yarmush ML. Selective targeting of pigmented retinal pigment epithelial (RPE) cells by a single pulsed laser irradiation: an in vitro study. Opt Express. 2008;16:10518-10528.
16. Burke JM, Zareba M. Sublethal photic stress and the motility of RPE phagosomes and melanosomes. Invest Ophthalmol Vis Sci. 2009; 50:1940-1947.
17. Vugler A, Carr AJ, Lawrence J, et al. Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol. 2008;214:347-361.
18. Bui BV, Kalloniatis M, Vingrys AJ. Retinal function loss after monocarboxylate transport inhibition. Invest Ophthalmol Vis Sci. 2004; 45:584-593.
19. Frenzel J, Richter J, Eschrich K. Pyruvate protects glucose-deprived Muller cells from nitric oxide-induced oxidative stress by radical scavenging. Glia. 2005;52:276-288.
20. Hegde KR, Varma SD. Prevention of oxidative stress to the retina by pyruvate: a preliminary report. Ophthalmologica. 2008;222: 194-198.
21. Paquin J, Aouffen M, De Grandpré E, Nadeau R, Langlois D, Mateescu MA. Neuroprotective and cardioprotective actions of an association of pyruvate, vitamin E and fatty acids. Arzneimittelforschung. 2005;55:359-369.
22. Turowski P, Adamson P, Sathia J, et al. Basement membranedependent modification of phenotype and gene expression in human retinal pigment epithelial ARPE-19 cells. Invest Ophthalmol Vis Sci. 2004;45:2786-2794.
23. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics Int. 2004;11:36-42.
24. Peirson SN, Butler JN, Foster RG. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res. 2003;31:e73.
25. Halestrap AP, Denton RM. The specificity and metabolic implications of the inhibition of pyruvate transport in isolated mitochondria and intact tissue preparations by alpha-Cyano-4-hydroxycinnamate and related compounds. Biochem J. 1975;148:97-106.
26. Saari JC, Nawrot M, Kennedy BN, et al. Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation. Neuron. 2001;29:739-748.
27. Cai X, Conley SM, Naash MI. RPE65: role in the visual cycle, human retinal disease, and gene therapy. Ophthalmic Genet. 2009;30:57-62.
28. Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma JX. RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc Natl Acad Sci U S A. 2005;102:12413-12418.
29. Janssen JJ, Kuhlmann ED, van Vugt AH, et al. Retinoic acid delays transcription of human retinal pigment neuroepithelium marker genes in ARPE-19 cells. Neuroreport. 2000;11:1571-1579.
30. Alizadeh M, Wada M, Gelfman CM, Handa JT, Hjelmeland LM. Downregulation of differentiation specific gene expression by oxidative stress in ARPE-19 cells. Invest Ophthalmol Vis Sci. 2001; 42:2706-2713.
31. Boulanger A, Redmond TM. Expression and promoter activation of the Rpe65 gene in retinal pigment epithelium cell lines. Curr Eye Res. 2002;24:368-375.
32. Kanuga N, Winton HL, Beauchene L, et al. Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies. Invest Ophthalmol Vis Sci. 2002;43:546-555.
33. Vollrath D, Feng W, Duncan JL, et al. Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc Natl Acad Sci U S A. 2001;98:12584-12589.
34. Gal A, Li Y, Thompson DA, et al. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet. 2000;26:270-271.
35. D'Cruz PM, Yasumura D, Weir J, et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet. 2000;9:645-651.
36. Andrae U, Singh J, Ziegler-Skylakakis K. Pyruvate and related alphaketoacids protect mammalian cells in culture against hydrogen peroxide-induced cytotoxicity. Toxicol Lett. 1985;28:93-98.
37. Giandomenico AR, Cerniglia GE, Biaglow JE, Stevens CW, Koch CJ. The importance of sodium pyruvate in assessing damage produced by hydrogen peroxide. Free Radic Biol Med. 1997;23:426-434.
38. 2in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity. Am J Physiol. 1995; 268:C227-C236.
39. Babich H, Liebling EJ, Burger RF, Zuckerbraun HL, Schuck AG. Choice of DMEM, formulated with or without pyruvate, plays an important role in assessing the in vitro cytotoxicity of oxidants and prooxidant nutraceuticals. In Vitro Cell Dev Biol Anim. 2009;45: 226-233.
40. Desagher S, Glowinski J, Premont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci. 1997;17: 9060-9067.
41. Wang X, Perez E, Liu R, Yan LJ, Mallet RT, Yang SH. Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells. Brain Res. 2007;1132:1-9.
42. Halestrap AP. The mitochondrial pyruvate carrier: kinetics and specificity for substrates and inhibitors. Biochem J. 1975;148:85-96.
43. Liu Y, Geng L, Suo Z. Differentiation effect of pyruvate and uridine on cultured U937-rho degrees cells. Ultrastruct Pathol. 2009;33: 160-164.
44. Nakayasu M, Saeki H, Tohda H, Oikawa A. Effects of sugars on melanogenesis in cultured melanoma cells. J Cell Physiol. 1977; 92:49-55.
45. Stanzel BV, Espana EM, Grueterich M, et al. Amniotic membrane maintains the phenotype of rabbit retinal pigment epithelial cells in culture. Exp Eye Res. 2005;80:103-112.
46. Campochiaro PA, Hackett SF. Corneal endothelial cell matrix promotes expression of differentiated features of retinal pigmented epithelial cells: implication of laminin and basic fibroblast growth factor as active components. Exp Eye Res. 1993;57:539-547.
47. Tezel TH, Del Priore LV. Reattachment to a substrate prevents apoptosis of human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol. 1997;235:41-47.
48. Tezel TH, Del Priore LV, Kaplan HJ. Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci. 2004;45:3337-3348.
49. Hunt RC, Davis AA. Altered expression of keratin and vimentin in human retinal pigment epithelial cells in vivo and in vitro. J Cell Physiol. 1990;145:187-199.
50. Lopes VS, Wasmeier C, Seabra MC, Futter CE. Melanosome maturation defect in Rab38-deficient retinal pigment epithelium results in instability of immature melanosomes during transient melanogenesis. Mol Biol Cell. 2007;18:3914-3927.
51. McKay BS, Irving PE, Skumatz CM, Burke JM. Cell-cell adhesion molecules and the development of an epithelial phenotype in cultured human retinal pigment epithelial cells. Exp Eye Res. 1997;65:661-671.
52. Riley PA. Mechanistic aspects of the control of tyrosinase activity. Pigment Cell Res. 1993;6:182-185.
53. Rozanowski B, Burke JM, Boulton ME, Sarna T, Rozanowska M. Human RPE melanosomes protect from photosensitized and ironmediated oxidation but become pro-oxidant in the presence of iron upon photodegradation. Invest Ophthalmol Vis Sci. 2008;49: 2838-2847.
54. Schraermeyer U, Heimann K. Current understanding on the role of retinal pigment epithelium and its pigmentation. Pigment Cell Res. 1999;12:219-236.
55. Ablonczy Z, Crosson CE. VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res. 2007;85:762-771.
56. Ghassemifar R, Lai CM, Rakoczy PE. VEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha-and mediates trans-epithelial resistance in cultured endothelial and epithelial cells. Cell Tissue Res. 2006;323:117-125.
57. Miyamoto N, de Kozak Y, Normand N, et al. PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier: a model for retinal edema. Ophthalmic Res. 2008;40:203-207.
58. Peng S, Adelman RA, Rizzolo LJ. Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions. Invest Ophthalmol Vis Sci. 2010;51:3216-3225.
59. Blaauwgeers HG, Holtkamp GM, Rutten H, et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris: evidence for a trophic paracrine relation. Am J Pathol. 1999;155:421-428.
60. Villarroel M, Garcia-Ramirez M, Corraliza L, Hernandez C, Simo R. Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells. Exp Eye Res. 2009;89:913-920.
61. Guerrin M, Moukadiri H, Chollet P, et al. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol. 1995;164:385-394.
62. Wu JH, Wang F, Xu P, Huang Q. [In vitro transdifferentiation of adult human retinal pigment epithelium cells to neuro-like cells induced by blocking VEGF expression.]. Zhonghua Yan Ke Za Zhi. 2005;41:114-118.
63. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D'Amore PA. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A. 2009;106: 18751-18756.
64. Saint-Geniez M, Maharaj AS, Walshe TE, et al. Endogenous VEGF is required for visual function: evidence for a survival role on Muller cells and photoreceptors. PLoS One. 2008;3:e3554.
65. Ohno-Matsui K, Morita I, Tombran-Tink J, et al. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol. 2001;189: 323-333.
66. Sonoda S, Spee C, Barron E, Ryan SJ, Kannan R, Hinton DR. A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat Protoc. 2009;4:662-673.
67. Sonoda S, Sreekumar PG, Kase S, et al. Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: relevance to age-related macular degeneration. Aging. 2010; 2:28-42.
68. Kannan R, Zhang N, Sreekumar PG, et al. Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. Mol Vis. 2006;12:1649-1659.
69. Slomiany MG, Rosenzweig SA. IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407. Invest Ophthalmol Vis Sci. 2004;45:2838-2847.
70. Sone H, Kawakami Y, Okuda Y, et al. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun. 1996;221:193-198.
71. Young TA, Wang H, Munk S, et al. Vascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent. Exp Eye Res. 2005;80:651-662.
72. Xiao Q, Zeng S, Ling S, Lv M. Up-regulation of HIF-1alpha and VEGF expression by elevated glucose concentration and hypoxia in cultured human retinal pigment epithelial cells. J Huazhong Univ Sci Technolog Med Sci. 2006;26:463-465.
73. Heimsath EG Jr, Unda R, Vidro E, Muniz A, Villazana-Espinoza ET, Tsin A. ARPE-19 cell growth and cell functions in euglycemic culture media. Curr Eye Res. 2006;31:1073-1080.
74. Tombran-Tink J, Shivaram SM, Chader GJ, Johnson LV, Bok D. Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci. 1995;15:4992-5003.
75. Klimanskaya I, Hipp J, Rezai KA, West M, Atala A, Lanza R. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells. 2004;6:217-245.
76. Sharma RK, Orr WE, Schmitt AD, Johnson DA. A functional profile of gene expression in ARPE-19 cells. BMC Ophthalmol. 2005;5:25.
77. Tian J, Ishibashi K, Honda S, Boylan SA, Hjelmeland LM, Handa JT. The expression of native and cultured human retinal pigment epithelial cells grown in different culture conditions. Br J Ophthalmol. 2005;89:1510-1517.
78. Coljee VW, Rotenberg MO, Tresini M, Francis MK, Cristofalo VJ, Sell C. Regulation of EPC-1/PEDF in normal human fibroblasts is posttranscriptional. J Cell Biochem. 2000;79:442-452.
79. Senanayake P, Calabro A, Hu JG, et al. Glucose utilization by the retinal pigment epithelium: evidence for rapid uptake and storage in glycogen, followed by glycogen utilization. Exp Eye Res. 2006; 83:235-246.
80. Kurtz MJ, Edwards RB. Influence of bicarbonate and insulin on pigment synthesis by cultured adult human retinal pigment epithelial cells. Exp Eye Res. 1991;53:681-684.